lhilaryl

ADPT Head and shoulders top

Penjualan
lhilaryl Diupdate   
NASDAQ:ADPT   Adaptive Biotechnologies Corporation
Broke strong support and uptrend line with a bearish head and shoulders top pattern.
With the current market situation and possible head and shoulders on IXIC, the incentive to short has increased.
Company losing money, EPS down 97.7% Q/Q, and the measly 98.40M sales do not justify a 7.23B market cap.
Of course as always, obey stop loss management principles.
Back to $44
Trading ditutup: target tercapai:
First target $44.50 reached strongly, closed half position and seeing future price action for complete exit
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.